Standard Biotools LAB
NASDAQ LAB
$0.64 -0.03 (-4.66%)
As of: Aug 20, 2026 · 3:53 PM EDT

Standard Biotools (LAB) Other Non-Current Liabilities (2010 - 2026)

Standard Biotools (LAB) posted quarterly Other Non-Current Liabilities of $4.4 million for Q1 2026, up 27.34% year-over-year from $3.5 million in Q1 2025, and up 265.76% quarter-over-quarter from $1.2 million in Q4 2025.

Standard Biotools (LAB) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Standard Biotools (LAB) has reported Other Non-Current Liabilities for 17 consecutive years, with $4.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities rose 27.34% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $4.4 million (up 27.34% YoY), while the FY2025 annual figure was $1.2 million, up 14.41% from the prior year.
  • Other Non-Current Liabilities grew to $4.4 million in Q1 2026 per LAB's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $4.4 million in Q1 2026 and bottomed at $550000.0 in Q1 2023.
  • Historically, Other Non-Current Liabilities has averaged $1.6 million across 5 years, with a median of $1.2 million in 2025.
  • Annual changes were most pronounced in 2023 — Other Non-Current Liabilities plunged 63.19% — and 2024, when it surged 412.73%.
  • Standard Biotools' Other Non-Current Liabilities stood at $961000.0 in 2022, then gained by 10.82% to $1.1 million in 2023, then slipped by 0.28% to $1.1 million in 2024, then gained by 14.41% to $1.2 million in 2025, then soared by 265.76% to $4.4 million in 2026.
  • Business Quant data shows LAB's Other Non-Current Liabilities at $4.4 million in Q1 2026, $1.2 million in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.12 Bn 193.52 Bn 7.27 Bn
2 Stryker 126.18 Bn 122.71 Bn 4.50 Bn
3 Medtronic 118.63 Bn 109.41 Bn 6.41 Bn
4 Boston Scientific 72.75 Bn 72.21 Bn 3.85 Bn
5 Edwards Lifesciences 52.10 Bn 47.85 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.68 Bn 31.57 Bn 2.18 Bn
8 Koninklijke Philips 26.32 Bn 23.00 Bn 4.55 Bn
9 Steris 23.10 Bn 22.62 Bn 684.20 Mn
10 Standard Biotools 251.69 Mn -225.03 Mn 10.54 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.11 Mn
Mar 31, 2026 4.44 Mn
Dec 31, 2025 1.22 Mn
Sep 30, 2025 1.20 Mn
Jun 30, 2025 1.25 Mn
Mar 31, 2025 3.49 Mn
Dec 31, 2024 1.06 Mn
Sep 30, 2024 1.51 Mn
Jun 30, 2024 1.52 Mn
Mar 31, 2024 2.82 Mn
Dec 31, 2023 1.07 Mn
Sep 30, 2023 1.09 Mn
Jun 30, 2023 843,000.00
Mar 31, 2023 550,000.00
Dec 31, 2022 961,000.00
Sep 30, 2022 1.17 Mn
Jun 30, 2022 1.30 Mn
Mar 31, 2022 1.49 Mn
Dec 31, 2021 882,000.00
Sep 30, 2021 954,000.00